Simcere Pharmaceutical Group Limited (HKG: 2096)
Hong Kong
· Delayed Price · Currency is HKD 6.91
+0.07 (1.02%)
Jan 3, 2025, 4:08 PM HKT
Simcere Pharmaceutical Group Market Cap
Simcere Pharmaceutical Group has a market cap or net worth of 17.19 billion as of January 3, 2025. Its market cap has decreased by -3.01% in one year.
Market Cap
17.19B
Enterprise Value
15.18B
Revenue
6.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
6.91
Market Cap Chart
Since October 27, 2020, Simcere Pharmaceutical Group's market cap has decreased from 29.84B to 17.19B, a decrease of -42.38%. That is a compound annual growth rate of -12.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 3, 2025 | 17.19B | -2.68% |
| Dec 31, 2024 | 17.67B | 0.31% |
| Dec 29, 2023 | 17.61B | -43.03% |
| Dec 30, 2022 | 30.91B | 30.83% |
| Dec 31, 2021 | 23.63B | 1.20% |
| Dec 31, 2020 | 23.35B | -21.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 149.74B |
| Hansoh Pharmaceutical Group Company | 98.87B |
| JD Health International | 84.92B |
| WuXi Biologics | 68.94B |
| Sinopharm Group | 64.91B |
| Innovent Biologics | 58.07B |
| Sino Biopharmaceutical | 55.71B |
| CSPC Pharmaceutical Group | 53.23B |